alchemia...what else...., page-16

From what I know, trial is still ongoing but near end, but 'they' (not sure who 'they' are) have started to collect/collate results from various sites. Apparently costlier way to do (i.e. in parallel, not sequentially), but will enable quicker reporting- end September latest. I'm also told that if ACL had the odd $30-$50 million available it could take this drug to market by itself. Given that fonda is, at best, $2.5 million/qtr revenue; something else would need happen